Khosla Ventures’ Alex Morgan on biotech’s challenges and solving drug delivery
Bio Pharma Dive
FEBRUARY 6, 2024
The life sciences investor has backed a number of startups working on technologies for delivering and manufacturing cell and gene medicines.
Let's personalize your content